Get the tools used by (smart)² investors.

SP500 2.1%DOW 1.6%FTSE 100 1.1%NIKKEI 0.7%OIL 0.9%GOLD 0.0%

Watchlists Ideas Screener Data Explorer Charts Saved Work

EBITDA - CAPEX for Agilent Technologies Inc

Join now and get access to the full platform

Search for company or ETF

0 results available. Select is focused ,type to refine list, press Down to open the menu,

A: Agilent Technologies Inc

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and A...

121.18 USD

Price

– USD

Fair Value

–

Upside

117.17 - 155.35

52-week range

Create Chart Create Model Add To Watchlist

Analysis

Fiscal Years

Trailing Twelve Months

Fiscal Halfs

Fiscal Quarters

Daily

Hide this widget

The following section summarizes insights on Agilent Technologies Inc's EBITDA - CAPEX:

Performance Summary

Agilent Technologies's latest twelve months ebitda - capex is 1.417 billion
Agilent Technologies's ebitda - capex for fiscal years ending October 2020 to 2024 averaged 1.457 billion.
Agilent Technologies's operated at median ebitda - capex of 1.423 billion from fiscal years ending October 2020 to 2024.
Looking back at the last 5 years, Agilent Technologies's ebitda - capex peaked in October 2022 at 1.703 billion.
Agilent Technologies's ebitda - capex hit its 5-year low in October 2020 of 1.234 billion.
Agilent Technologies's ebitda - capex decreased in 2023 (1.388 billion, -18.5%) and increased in 2020 (1.234 billion, +9.6%), 2021 (1.537 billion, +24.6%), 2022 (1.703 billion, +10.8%), and 2024 (1.423 billion, +2.5%).

How does Agilent Technologies's EBITDA - CAPEX benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Agilent Technologies Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Agilent Technologies EBITDA - CAPEX Benchmarks
Name	Ticker	EBITDA - CAPEX
Standard Biotools Inc	NASDAQGS:LAB	-126.3 M
Seer Inc	NASDAQGS:SEER	-97.509 M
Quanterix Corp	NASDAQGM:QTRX	-45.171 M
Cytek Biosciences Inc	NASDAQGS:CTKB	-19.436 M
Healthcare	SECTOR:HLTH.US	-10.895 M
Illumina Inc	NASDAQGS:ILMN	573 M
Charles River Laboratories	NYSE:CRL	665.2 M
Revvity Inc	NYSE:RVTY	751 M
Waters Corporation	NYSE:WAT	886.9 M
Agilent Technologies Inc	NYSE:A	1.417 B
Danaher Corporation	NYSE:DHR	6.114 B
Thermo Fisher Scientific Inc	NYSE:TMO	9.374 B

Metric Usage: EBITDA - CAPEX

Hide this widget

ebitda_less_capex

Slug

number

Datatype

text

Format

current

Default Period

FY, Q, LTM, YTD

Periods Supported

Free

Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to EBITDA - CAPEX in the efficiency category include:

Unlevered Free Cash Flow Margin - Unlevered free cash flow expressed as a percent of revenue.
Selling, General and Admin Margin - The sum of selling, general and administrative expenses as a percent of revenue.
Gross Profit Margin CAGR (10y) - Ten-year compound annual growth rate in gross profit margin.
Net Income to Stockholders Margin CAGR (10y) - Ten-year compound annual growth rate in net income to stockholders margin.

View Full List

Search for metric or datapoint

EBITDA - CAPEX

Earnings before interest, taxes, depreciation and amortization (EBITDA) minus capital expenditures.

Definition of EBITDA - CAPEX

Hide this widget

Earnings before interest, taxes, depreciation and amortization (EBITDA) minus capital expenditures.

Sector Benchmark Analysis

Sector

Industry Group

Industry

Hide this widget

The chart above depicts the distribution of ebitda - capex for companies operating in the Healthcare sector in the Developed economic region. Over 2,530 companies were considered in this analysis, and 2,431 had meaningful values. The average ebitda - capex of companies in the sector is 36.694 M with a standard deviation of 260 M.

Agilent Technologies Inc's EBITDA - CAPEX of 1.417 B ranks in the 97.2% percentile for the sector. The following table provides additional summary stats:

EBITDA - CAPEX In The Healthcare Sector
Economic Risk Region	Developed
Total Constituents	2,533
Included Constituents	2,431
Min	-274.1 M
Max	2.842 B
Median	-2.41 M
Mean	36.694 M
Standard Deviation	260 M

You can find companies with similar ebitda - capex using this stock screener.